One patient had a leiomyosarcoma, where alterations of the mTOR pathway have been described, such as the overexpression of RICTOR, a major component of the mTOR complex 2, which might contribute to the pathogenesis of well-differentiated leiomyosarcoma [38,39]. Here, MTOR is linked to leiomyosarcoma.